Peptone

Peptone is a biotechnology company developing novel first-in-class small molecule therapeutics targeting intrinsically disordered proteins (IDPs)—proteins lacking a fixed 3D structure that are linked to diseases like cancer and inflammation but are traditionally considered "undruggable." The company combines proprietary atomistic biophysics experiments (including NMR and hydrogen-exchange mass spectrometry), supercomputing, and AI/machine learning to design small molecules against these targets, serving pharmaceutical and biotech partners such as Evotec.